WO2012019203A3 - Therapeutic agent for intranasal administration and method of making and using same - Google Patents
Therapeutic agent for intranasal administration and method of making and using same Download PDFInfo
- Publication number
- WO2012019203A3 WO2012019203A3 PCT/US2011/051976 US2011051976W WO2012019203A3 WO 2012019203 A3 WO2012019203 A3 WO 2012019203A3 US 2011051976 W US2011051976 W US 2011051976W WO 2012019203 A3 WO2012019203 A3 WO 2012019203A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- therapeutic agent
- intranasal administration
- making
- same
- nordihydrocapsaicin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Abstract
The present invention provides a composition suitable for intranasal administration comprising capsaicin, dihydrocapsaicin, and nordihydrocapsaicin in the form of capsicum used as a therapeutic agent.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/849,088 US20100322961A1 (en) | 2007-03-30 | 2010-08-03 | Intranasal Drug Delivery System |
US12/849,088 | 2010-08-03 | ||
US40539010P | 2010-10-21 | 2010-10-21 | |
US61/405,390 | 2010-10-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012019203A2 WO2012019203A2 (en) | 2012-02-09 |
WO2012019203A3 true WO2012019203A3 (en) | 2012-03-29 |
Family
ID=45560117
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/051976 WO2012019203A2 (en) | 2010-08-03 | 2011-09-16 | Therapeutic agent for intranasal administration and method of making and using same |
PCT/US2011/051981 WO2012019204A2 (en) | 2010-08-03 | 2011-09-16 | Therapeutic agent for intranasal administration and method of making and using same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/051981 WO2012019204A2 (en) | 2010-08-03 | 2011-09-16 | Therapeutic agent for intranasal administration and method of making and using same |
Country Status (1)
Country | Link |
---|---|
WO (2) | WO2012019203A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120171316A1 (en) * | 2012-03-14 | 2012-07-05 | Forces Of Nature, Inc. | Method for manufacturing homeopathic mixtures |
US20120183624A1 (en) * | 2012-03-23 | 2012-07-19 | Forces Of Nature, Inc. | Method for manufacturing homeopathic personal care products |
WO2014031964A1 (en) * | 2012-08-24 | 2014-02-27 | Vr1, Inc. | Composition for the treatment of migraine headaches |
MX370929B (en) | 2012-10-28 | 2020-01-08 | Revance Therapeutics Inc | Compositions and methods for safe treatment of rhinitis. |
US11484580B2 (en) | 2014-07-18 | 2022-11-01 | Revance Therapeutics, Inc. | Topical ocular preparation of botulinum toxin for use in ocular surface disease |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040151792A1 (en) * | 2001-06-20 | 2004-08-05 | Tripp Matthew L. | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US20090069433A1 (en) * | 2007-09-10 | 2009-03-12 | Wayne Jeffrey Perry | Nasal rinse additive |
US20090093446A1 (en) * | 2007-10-05 | 2009-04-09 | Winston Laboratories, Inc. | Method for alleviating keratoconjunctivitis sicca |
US20090312724A1 (en) * | 2007-06-28 | 2009-12-17 | Cydex Pharmaceuticals, Inc. | Nasal and Ophthalmic Delivery of Aqueous Corticosteroid Solutions |
-
2011
- 2011-09-16 WO PCT/US2011/051976 patent/WO2012019203A2/en active Application Filing
- 2011-09-16 WO PCT/US2011/051981 patent/WO2012019204A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040151792A1 (en) * | 2001-06-20 | 2004-08-05 | Tripp Matthew L. | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US20090312724A1 (en) * | 2007-06-28 | 2009-12-17 | Cydex Pharmaceuticals, Inc. | Nasal and Ophthalmic Delivery of Aqueous Corticosteroid Solutions |
US20090069433A1 (en) * | 2007-09-10 | 2009-03-12 | Wayne Jeffrey Perry | Nasal rinse additive |
US20090093446A1 (en) * | 2007-10-05 | 2009-04-09 | Winston Laboratories, Inc. | Method for alleviating keratoconjunctivitis sicca |
Non-Patent Citations (1)
Title |
---|
ALCON: "Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms", 15 April 2008 (2008-04-15), Retrieved from the Internet <URL:http://invest.alconinc.com/phoenix.zhtml?c=130946&p=irol-newsArticlePrint&ID=1129960&highlight=> [retrieved on 20120111] * |
Also Published As
Publication number | Publication date |
---|---|
WO2012019203A2 (en) | 2012-02-09 |
WO2012019204A3 (en) | 2012-03-22 |
WO2012019204A2 (en) | 2012-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL269858A (en) | Pyridone and aza-pyridone compounds, pharmaceutical composition and kits comprising the same and uses thereof | |
IL269322B (en) | Methylphenidate-prodrugs, processes of making and using the same | |
IL252154A0 (en) | Anti-dr5 antibodies, compositions comprising the same and uses thereof | |
IL227963A0 (en) | Cytotxic benzodiazepine derivatives, compositions comprising the same and uses thereof | |
HK1220631A1 (en) | Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same | |
WO2011130615A3 (en) | Preparation of lacosamide | |
EP2670733A4 (en) | Hdac inhibitors and therapeutic methods using the same | |
ZA201305571B (en) | Bcl-2/bcl-xl inhibitors and therapeutic methods using the same | |
WO2011002808A8 (en) | Hcv protease inhibitors and uses thereof | |
PL2554050T3 (en) | Combined chlorine agent, and manufacturing method and method of use for same | |
WO2011086584A3 (en) | Improved process for the preparation of amide intermediates and their use thereof | |
WO2011150201A3 (en) | Azolyl amide compounds and methods of use thereof | |
WO2012051117A3 (en) | Substituted benzamides and their uses | |
WO2012019203A3 (en) | Therapeutic agent for intranasal administration and method of making and using same | |
EP2361907A4 (en) | The five crystal forms of the nicousamide, the preparation methods, the pharmaceutical compositions and the uses thereof | |
WO2013155338A8 (en) | Substituted benzamides and their uses | |
SG10201604468QA (en) | Shk-based pharmaceutical compositions and methods of manufacturing and using the same | |
HK1200392A1 (en) | Acetaminophen conjugates, compositions and methods of use thereof | |
IL227816A0 (en) | Peptide library, constructs comprising the same and methods of use of the same | |
IL222780A0 (en) | Pharmaceutical compositions comprising paracetamol and process for preparing the same | |
SG11201403785UA (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
WO2011088272A9 (en) | Selective ampd2 inhibitors and methods for using the same | |
IL230655A0 (en) | N-hetero-ring-substituted amide derivatives, compositions comprising the same and uses thereof | |
WO2014159501A3 (en) | Processes for preparing tetrahydroisoquinolines | |
WO2012139074A3 (en) | Migrastatins and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11815427 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205N DATED 09/04/2013) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11815427 Country of ref document: EP Kind code of ref document: A2 |